Proliferation of vascular smooth muscle cells (VSMC) is important in the pathogenesis of atherosclerosis, post-transplantation atherosclerosis, vascular graft occlusion, post-angioplasty restenosis, and vascular remodeling in hypertension. The insulin-like growth factor I receptor (IGF IR) is a membrane tyrosine-kinase receptor that is expressed at high levels on VSMC. We have shown that this receptor is an important mediator of VSMC growth responses in vitro. The major objective of this proposal is to study the interactions between this receptor and other heterologous growth factors that are important in VSMC growth. These include platelet- derived growth factor (PDGF), basic fibroblast growth factor (bFGF), angiotensin II (ang II), and alpha-thrombin. We have cloned a full-length cDNA encoding the rat IGF IR and shown that antisense transcription of an IGF IR cDNA in VSMC has marked inhibitory effects on VSMC growth responses. The IGF IR appears to be at a convergence point for the action of other growth factors. Thus one can inhibit ang II and alpha-thrombin induced DNA synthesis in VSMC by downregulating this receptor. Multiple growth factors upregulate IGF IR number on VSMC, and this upregulation is likely essential for their mitogenic effects.
The specific aims of the grant are: 1) To determine biochemical and molecular signaling events important in growth factor regulation of the IGF I receptor on VSMC. 2) To characterize crosstalk between the IGF IR and other growth factors by determining the effects of changes in IGF IR concentration on growth factor-triggered distal signaling events in VSMC. 3) Exploration of the role of the IGF IR in vascular growth responses in vivo through use of expression cassettes encoding a dominant-negative IGF IR mutant or antisense IGF IR RNA. We will use recombinant adenovirus to express kinase-deficient receptors or antisense receptor RNA transcripts in VSMC. This technology will allow us to address directly the function of the IGF receptor in vascular growth in vivo. Methodologies to be used include northern and solution hybridization/RNase protection assays, in situ hybridization, gene delivery techniques through adenoviral vectors, immunohistochemistry, western ligand blotting, radioligand binding assays, radioimmunoassays, immunoprecipitation and western blotting, kinase assays, morphometry, and studies of promoter/reporter constructs. These studies are critical to understanding the function of the IGF IR as it relates to mitogenic responses to other growth factors. It should provide the basis for the development of rational approaches to address vascular complications of hypertension, atherosclerosis, post-angioplasty restenosis, and post-transplantation atherosclerosis.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL047035-06
Application #
2392679
Study Section
Pathology A Study Section (PTHA)
Project Start
1991-08-01
Project End
1999-03-31
Budget Start
1997-04-01
Budget End
1998-03-31
Support Year
6
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Emory University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
042250712
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Anwar, A; Zahid, A A; Scheidegger, K J et al. (2002) Tumor necrosis factor-alpha regulates insulin-like growth factor-1 and insulin-like growth factor binding protein-3 expression in vascular smooth muscle. Circulation 105:1220-5
Sayeski, P P; Ali, M S; Frank, S J et al. (2001) The angiotensin II-dependent nuclear translocation of Stat1 is mediated by the Jak2 protein motif 231YRFRR. J Biol Chem 276:10556-63
Giraud, S; Greco, A; Brink, M et al. (2001) Translation initiation of the insulin-like growth factor I receptor mRNA is mediated by an internal ribosome entry site. J Biol Chem 276:5668-75
Okura, Y; Brink, M; Zahid, A A et al. (2001) Decreased expression of insulin-like growth factor-1 and apoptosis of vascular smooth muscle cells in human atherosclerotic plaque. J Mol Cell Cardiol 33:1777-89
Brink, M; Price, S R; Chrast, J et al. (2001) Angiotensin II induces skeletal muscle wasting through enhanced protein degradation and down-regulates autocrine insulin-like growth factor I. Endocrinology 142:1489-96
Keller, P F; Verin, V; Ziegler, T et al. (2001) Gamma-irradiation markedly inhibits the hydrated collagen gel contradiction by arterial smooth muscle cells. J Investig Med 49:258-64
Du, J; Brink, M; Peng, T et al. (2001) Thrombin regulates insulin-like growth factor-1 receptor transcription in vascular smooth muscle: characterization of the signaling pathway. Circ Res 88:1044-52
Scheidegger, K J; James, R W; Delafontaine, P (2000) Differential effects of low density lipoproteins on insulin-like growth factor-1 (IGF-1) and IGF-1 receptor expression in vascular smooth muscle cells. J Biol Chem 275:26864-9
Anwar, A; Zahid, A A; Phillips, L et al. (2000) Insulin-like growth factor binding protein-4 expression is decreased by angiotensin II and thrombin in rat aortic vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 20:370-6
Delafontaine, P; Brink, M (2000) The growth hormone and insulin-like growth factor 1 axis in heart failure. Ann Endocrinol (Paris) 61:22-6

Showing the most recent 10 out of 38 publications